Recent advances in the identification and quantification of xylazine and medetomidine in biological specimens
Open Access
- 14 October 2025
- journal article
- review article
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (20) , 1295-1303
Abstract
Xylazine is a veterinary sedative that is frequently detected in the illicit drug supply, often found mixed with illicitly manufactured fentanyl (IMF). It has been detected in the blood of overdose victims and patients who use illicit drugs. Xylazine is not approved for use in humans. It is an alpha-2-adrenergic receptor agonist that causes deep sedation that is non-responsive to naloxone, the antidote for opioid overdose. Chronic exposure to xylazine has been linked to severe wounds that can progress to amputation. Medetomidine is another related veterinary sedative that has more recently emerged as an adulterant in IMF. Medetomidine is also an alpha-2-adrenergic agonist, and in veterinary medicine it is known to be significantly more potent than xylazine. The mixture of these drugs with IMF complicates the treatment of patients exposed to these drugs. Wider availability of analytical methods to detect xylazine, and now medetomidine, is crucial for responding to these health threats and increasing knowledge on the harms and potential therapies for exposed patients. This review covers what is currently known about these drugs, including observed concentrations in various biospecimens, expected major metabolites and windows of detection, and available analytical approaches for detecting exposure.Keywords
This publication has 61 references indexed in Scilit:
- Medetomidine Infiltrates the US Illicit Opioid MarketJAMA, 2024
- Direct analysis in real time mass spectrometry (DART-MS/MS) for rapid urine opioid detection in a clinical settingClinica Chimica Acta, 2024
- Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022JAMA Network Open, 2024
- Rapid detection of 10 benzodiazepines and metabolites in blood and urine using DART‐MS/MSDrug Testing and Analysis, 2023
- Xylazine-Involved Fatal and Nonfatal Drug Overdoses in Tennessee From 2019 to 2022JAMA Network Open, 2023
- Direct analysis in real‐time tandem mass spectrometry method for the rapid screening of 11 new psychoactive substances in blood and urineRapid Communications in Mass Spectrometry, 2023
- Ambient ionization mass spectrometry applied to new psychoactive substance analysisMass Spectrometry Reviews, 2021
- Drug Screening Using Liquid Chromatography Quadrupole Time-of-Flight (LC-QqTOF) Mass Spectrometry2018
- Clinical Pharmacokinetics and Pharmacodynamics of DexmedetomidineClinical Pharmacokinetics, 2017
- Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC–MS, LC–MS n , and LC–HR-MS nAnalytical and Bioanalytical Chemistry, 2013